Skip to main content
SpringerLink
Log in

Drug Effects on ECGs

  • Chapter
  • First Online:
New Concepts in ECG Interpretation

  • 2002 Accesses

Abstract

Several drugs used in clinical practice can influence the ECG behaviour. It is very important for the clinician to know the most common ECG alterations due to drug administration.

Starting from three clinical cases, this chapter discusses about drugs inducing ECG modifications. In each case there is an accurate ECG analysis, the way to get to the correct diagnosis and a theoretical description of the possible mechanisms.

The first case deals with QT prolongation due to psychotropic drugs, the second case is about IC antiarrhythmic drugs effect, and the last case shows the ECG modifications due to digoxin.

In the last part of the chapter there is an overview about the common used drugs and their mechanisms and correlate ECG modifications.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
eBook
USD 16.99
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Hardcover Book
USD 99.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Similar content being viewed by others

References

  1. van Noord C, Eijgelsheim M, Stricker BHC. Drug- and non-drug-associated QT interval prolongation. Br J Clin. 2010;70(1):16–23.

    Article  Google Scholar 

  2. Newton-Cheh C, Eijgelsheim M, Rice KM, et al. Common variants at ten loci influence QT interval duration in the QTGEN Study. Nat Genet. 2009;41(4):399–406.

    Article  CAS  Google Scholar 

  3. Arking DE, Pfeufer A, Post W, et al. A common genetic variant in the NOS1 regulator NOS1AP modulates cardiac repolarization. Nat Genet. 2006;38(6):644–51.

    Article  CAS  Google Scholar 

  4. Surawicz B, Knilans T. Chou’s electrocardiography in clinical practice. 6th ed. Philadelphia: Saunders Elsevier; 2008.

    Google Scholar 

  5. Oreto G. Elettrocardiogramma: un mosaico a 12 tessere. 1st ed. Torino: Centro scientifico editore Edi-Ermes; 2009.

    Google Scholar 

  6. Funck-Brentano C, Jaillon P. Rate-corrected QT interval: techniques and limitations. Am J Cardiol. 1993;72(6):17B–22B.

    Article  CAS  Google Scholar 

  7. Locati ET, Bagliani G, Padeletti L. Normal ventricular repolarization and QT interval. Card Electrophysiol Clin. 2017;9(3):487–513.

    Article  Google Scholar 

  8. Glassman AH, Bigger JT. Antipsychotic drugs: prolonged QTc interval, torsade de pointes, and sudden death. Am J Psychiatry. 2001;158(11):1774–82.

    Article  CAS  Google Scholar 

  9. AIFA. Cardiotossicità dell’aloperidolo. Le basi scientifiche delle disposizioni regolatorie. Farmacovigilanza. 2007.

    Google Scholar 

  10. Drolet B, Rousseau G, Daleau P, et al. Pimozide (Orap®) prolongs cardiac repolarization by blocking the rapid component of the delayed rectifier potassium current in native cardiac myocytes. J Cardiovasc Pharmacol Ther. 2001;6(3):255–60.

    Article  CAS  Google Scholar 

  11. Woosley RL, Heise CW, Romero K. CredibleMeds.org: what does it offer? Trends Cardiovasc Med. 2017;17:30114–7.

    Google Scholar 

  12. Crijns HJ, Van Gelder IC, Lie KI. Supraventricular tachycardia mimicking ventricular tachycardia during flecainide treatment. Am J Cardiol. 1988;62:1303–6.

    Article  CAS  Google Scholar 

  13. Nabar A, Rodriguez LM, Timmermans C, Smeets JL, Wellens HJ. Radiofrequency ablation of “class IC atrial flutter” in patients with resistant atrial fibrillation. Am J Cardiol. 1999;83:785–7.

    Article  CAS  Google Scholar 

  14. Falk RH. Proarrhythmia in patients treated for atrial fibrillation or flutter. Ann Intern Med. 1992;117:141–50.

    Article  CAS  Google Scholar 

  15. McNamara RL, Tamariz LJ, Segal JB, Bass EB. Management of atrial fibrillation: review of the evidence for the role of pharmacologic therapy, electrical cardioversion, and echocardiography. Ann Intern Med. 2003;139:1018–33.

    Article  Google Scholar 

  16. Crijns HJGM. Clinical manifestations of use- and reverse-use dependence. In: Crijns HJGM, editor. Changes of intracardiac conduction induced by antiarrhythmic drugs: importance of use- and reverse use-dependence. Groningen: Knoop; 1993. p. 38–105.

    Google Scholar 

  17. Wiesfelda ACP, Ansinkb JM, van Veldhuisena DJ, van Gelde IC. Broad complex tachycardia during treatment of atrial fibrillation with a 1c antiarrhythmic drug: ventricular or supraventricular proarrhythmia? Int J Cardiol. 2006;107:140–1.

    Article  Google Scholar 

  18. Echt DS, Liebson PR, Mitchell LB, et al. Mortality and morbidity in patients receiving encainide, flecainide, or placebo. The cardiac arrhythmia suppression trial. N Engl J Med. 1991;324:781–8.

    Article  CAS  Google Scholar 

  19. De Paola AA, Horowitz LN, Morganroth J, et al. Influence of left ventricular dysfunction on flecainide therapy. J Am Coll Cardiol. 1987;9:163–8.

    Article  Google Scholar 

  20. Anno T, Hondeghem LM. Interactions of flecainide with guinea pig cardiac sodium channels. Importance of activation unblocking to the voltage dependence of recovery. Circ Res. 1990;66:789–803.

    Article  CAS  Google Scholar 

  21. Hilliard FA, Steele DS, Laver D, et al. Flecainide inhibits arrhythmogenic Ca2+ waves by open state block of ryanodine receptor Ca2+ release channels and reduction of Ca2+ spark mass. J Mol Cell Cardiol. 2010;48:293–301.

    Article  CAS  Google Scholar 

  22. Zipes DP, Libby P, Bonow RO, Braunwald E. Braunwald’s heart disease: a textbook of cardiovascular medicine. 10th ed. Oxford: Elsevier; 2014.

    Google Scholar 

  23. Holstege CP, Eldridge DL, Rowden AK. ECG manifestations: the poisoned patient. Emerg Med Clin North Am. 2006;24(1):159–77.

    Article  Google Scholar 

  24. Hohnloser SH, Halperin JL, Camm AJ, et al. Behalf of the PALLAS Investigators interaction between digoxin and dronedarone in the PALLAS trial. Circ Arrhythm Electrophysiol. 2014;7:1019–25.

    Article  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Clinica di Cardiologia e Aritmologia, Università Politecnica delle Marche, Ancona, Italy

    Paolo Bonelli, Irene Giannini, Maria Vittoria Matassini & Alessio Menditto

Authors
  1. Paolo Bonelli
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Irene Giannini
    View author publications

    You can also search for this author in PubMed Google Scholar

  3. Maria Vittoria Matassini
    View author publications

    You can also search for this author in PubMed Google Scholar

  4. Alessio Menditto
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Cardiology Clinic, Marche Polytechnic University Cardiology Clinic, Ancona, Italy

    Alessandro Capucci

Rights and permissions

Reprints and permissions

Copyright information

© 2019 Springer Nature Switzerland AG

About this chapter

Check for updates. Verify currency and authenticity via CrossMark

Cite this chapter

Bonelli, P., Giannini, I., Matassini, M.V., Menditto, A. (2019). Drug Effects on ECGs. In: Capucci, A. (eds) New Concepts in ECG Interpretation. Springer, Cham. https://doi.org/10.1007/978-3-319-91677-4_13

Download citation

  • DOI: https://doi.org/10.1007/978-3-319-91677-4_13

  • Published:

  • Publisher Name: Springer, Cham

  • Print ISBN: 978-3-319-91676-7

  • Online ISBN: 978-3-319-91677-4

  • eBook Packages: MedicineMedicine (R0)

Publish with us

Policies and ethics

Search

Navigation